Aspirin-Exacerbated Respiratory Disease in a Pediatric Patient Treated with Mepolizumab.
作者信息
Méndez Sánchez Alejandra, Gutiérrez Martínez Jose Ramón, Coca Pelaz Andrés, Vázquez Piñera Maria Antonia
机构信息
Unidad de Neumoalergia Infantil, Área de Gestión Clínica de Pediatría, Hospital Universitario Central de Asturias, Oviedo, España.
Unidad de Neumoalergia Infantil, Área de Gestión Clínica de Pediatría, Hospital Universitario Central de Asturias, Oviedo, España.
出版信息
Arch Bronconeumol (Engl Ed). 2019 Jan;55(1):55-57. doi: 10.1016/j.arbres.2018.04.012. Epub 2018 May 28.
PMID:29853258
Abstract
摘要
相似文献
1
Aspirin-Exacerbated Respiratory Disease in a Pediatric Patient Treated with Mepolizumab.
Arch Bronconeumol (Engl Ed). 2019 Jan;55(1):55-57. doi: 10.1016/j.arbres.2018.04.012. Epub 2018 May 28.
2
Mepolizumab does not prevent all aspirin-induced reactions in patients with aspirin-exacerbated respiratory disease: A case series.美泊利单抗不能预防阿司匹林加重性呼吸系统疾病患者的所有阿司匹林诱发反应：病例系列报道
J Allergy Clin Immunol Pract. 2021 Mar;9(3):1384-1385. doi: 10.1016/j.jaip.2020.09.007. Epub 2020 Sep 19.
3
Mepolizumab for the treatment of aspirin-exacerbated respiratory disease associated with coronary spasm.美泊利单抗用于治疗与冠状动脉痉挛相关的阿司匹林加重性呼吸疾病。
J Allergy Clin Immunol Pract. 2019 Mar;7(3):1076-1077. doi: 10.1016/j.jaip.2018.07.045. Epub 2018 Aug 29.
4
A retrospective analysis of mepolizumab in subjects with aspirin-exacerbated respiratory disease.美泊利单抗治疗阿司匹林加重的呼吸道疾病患者的回顾性分析
J Allergy Clin Immunol Pract. 2018 May-Jun;6(3):1045-1047. doi: 10.1016/j.jaip.2018.01.038. Epub 2018 Mar 6.
5
Aspirin desensitization achieved after omalizumab treatment in a patient with aspirin-exacerbated urticaria and respiratory disease.在一名患有阿司匹林诱发的荨麻疹和呼吸道疾病的患者中，奥马珠单抗治疗后实现了阿司匹林脱敏。
J Investig Allergol Clin Immunol. 2015;25(2):133-5.
6
Dupilumab increases aspirin tolerance in aspirin-exacerbated respiratory disease.度普利尤单抗可提高阿司匹林诱发的呼吸道疾病患者对阿司匹林的耐受性。
Ann Allergy Asthma Immunol. 2021 Jun;126(6):738-739. doi: 10.1016/j.anai.2021.03.010. Epub 2021 Mar 19.
7
Poor control of asthma symptoms with interleukin-5 inhibitors in four patients with aspirin-exacerbated respiratory disease.在四名阿司匹林诱发的呼吸道疾病患者中，白细胞介素-5抑制剂对哮喘症状的控制不佳。
Ann Allergy Asthma Immunol. 2020 Jan;124(1):102-104. doi: 10.1016/j.anai.2019.09.023. Epub 2019 Oct 9.
8
Aspirin tolerance following omalizumab therapy in a patient with aspirin-exacerbated respiratory disease.奥马珠单抗治疗阿司匹林诱发的呼吸道疾病患者后的阿司匹林耐受性
Allergol Immunopathol (Madr). 2013 May-Jun;41(3):208-10. doi: 10.1016/j.aller.2012.02.005. Epub 2012 Jul 2.
9
Mepolizumab utility in successful aspirin desensitization in aspirin-exacerbated respiratory disease in a refractory case.美泊利单抗在一例难治性阿司匹林加重性呼吸系统疾病患者成功进行阿司匹林脱敏治疗中的应用。
Ann Allergy Asthma Immunol. 2019 Sep;123(3):311-312. doi: 10.1016/j.anai.2019.06.012. Epub 2019 Jun 24.
10
Efficacy of various dosing frequencies of dupilumab in patients with aspirin-exacerbated respiratory disease.度普利尤单抗不同给药频率对阿司匹林加重的呼吸系统疾病患者的疗效
J Allergy Clin Immunol Pract. 2024 Jun;12(6):1647-1648. doi: 10.1016/j.jaip.2024.03.011. Epub 2024 Mar 12.
引用本文的文献
1
An Overview of Off-Label Use of Humanized Monoclonal Antibodies in Paediatrics.人源化单克隆抗体在儿科领域的超说明书使用概述。
Medicina (Kaunas). 2022 Apr 29;58(5):625. doi: 10.3390/medicina58050625.
Zotero 插件